Shreya Agarwal/LInkedIn
Oct 17, 2025, 06:38
Not All Thrombotic Microangiopathies Behave the Same – Published in RPTH
RPTH Journal posted on LinkedIn:
”Not all thrombotic microangiopathies (TMAs) behave the same, and they don’t all respond to complement blockade.
In a new study, Shreya Agarwal and team describe a subset of patients with plasminogen (PLG) mutations who experienced recurrent TMA despite standard therapy. Their response to anticoagulation hints at an alternative disease pathway worth exploring.
Coauthors: Nicola Pozzi; Senthil Sukumar, Camila Masias, Anuja Java, Spero Cataland”
Read the full article here.
Title: Plasminogen mutation–associated thrombotic microangiopathy and role of anticoagulation: a single institution case series
Stay updated with Hemostasis Today.
-
Apr 29, 2026, 01:15Yuriy Prokopenko: Honored to Attend the 12th Symposium on Hemostasis
-
Apr 28, 2026, 16:26Andrew Zapfel: The ASH’s Consortium on Newborn Screening in Africa Brought Together Over 40 People From 10 Countries
-
Apr 28, 2026, 16:22Beth Fernandes: Bringing Alaska’s First Civilian Medevac Whole Blood Program To Life
-
Apr 28, 2026, 15:47Dianne E. van der Wal: How Rat and Human Platelet Vesicles Are Different
-
Apr 28, 2026, 15:14Elaheh Mansouri: Platelet Clumping Is a Common Pre-Analytical and Analytical Challenge in Haematology
-
Apr 28, 2026, 15:11Hans Vrielink: Honoured to Receive the Cohn the Laval Award at the ASFA/WAA
-
Apr 28, 2026, 15:07Stan Van Boeckel: Pitfalls in Early Drug Discovery
-
Apr 28, 2026, 15:02Stephani Carolina Salvatierra Moreno: Our Study on Microneedling and PRP Has Been Published
-
Apr 28, 2026, 14:57Steven Heylen: Hydrolyzed Collagen Injections for Knee Osteoarthritis as a New Treatment Option